跳至主要内容
临床试验/ISRCTN11812525
ISRCTN11812525已完成2 期

A phase II study of preoperative chemoradiation with UFT-E plus leucovorin and the translational research for detection of predictive markers in the patients with locally advanced resectable rectal cancer

ational Cancer Center0 个研究点目标入组 121 人开始时间: 2016年7月25日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
121

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Histologically diagnosed adenocarcinoma of rectum
  • 2. Located within 8cm from anal verge
  • 3. cT3/4 by rectal MRI+/- endorectal ultrasound
  • 4. 18 years old or more
  • 5. ECOG performance status <=2
  • 6. No previous chemotherapy
  • 7. No previous radiotherapy to pelvis
  • 8. Adequate bone marrow, hepatic, and renal function

排除标准

  • 1. Rectal cancer of histology other than adenocarcinoma
  • 2. Adenocarcinoma developed from inflammatory bowel disease
  • 3. Presence of distant metastases
  • 4. Existence of unresected synchronous colon cancer
  • 5. Unresolved bowel obstruction
  • 6. Clinically unresectable disease
  • 7. Uncontrolled cardiovascular disease
  • 8. Uncontrolled active infection
  • 9. History of other malignancies within 5 years from screening
  • 10. History of organ transplantation that necessitates immunosuppressive treatment
  • 11. Uncontrolled epileptic disease or psychiatric disease
  • 12. Pregnant or breastfeeding women, or women with child-bearing potential who are not compliant to 13. Contraception policy of this study

研究者

发起方
ational Cancer Center

相似试验